Inventor
Yufen Zhao
Inventor
Pennington, NJ, US
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds27%
A61KPreparations for medical, dental or toiletry purposes22%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07KPeptides6%
C07HSugars2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
H04BTransmission1%
H04WWireless communication networks1%
PatentTitleYear
10,932,231Resource selection for device to device discovery or communication202110,744,150Cyclic dinucleotides as anticancer agents202010,519,187Cyclic dinucleotides as anticancer agents20199,708,316'TGFβR antagonists'20179,556,178'Imidazotriazinecarbonitriles useful as kinase inhibitors'20179,492,460'Carbazole compounds useful as bromodomain inhibitors'20169,427,442'Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds'20169,371,328'Imidazopyridazinecarbonitriles useful as kinase inhibitors'20169,273,014'Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof'20169,273,057'Imidazotriazinecarbonitriles useful as kinase inhibitors'20169,242,941'Alkyl, fluoroalkyl-1,4-benzodiazepinone compounds'20168,999,918'Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof'20158,940,736'Imidazotriazinecarbonitriles useful as kinase inhibitors'20158,466,171'Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function'20138,389,527'Substituted imidazopyridazines useful as kinase inhibitors'20138,252,795'Imidazopyridazinecarbonitriles useful as kinase inhibitors'20128,067,582'Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function'20117,846,931'Pyrrolotriazine compounds as kinase inhibitors'20107,514,435'Pyrrolotriazine kinase inhibitors'20097,358,256'ATP competitive kinase inhibitors'20087,312,209'Acridone inhibitors of IMPDH enzyme'20077,297,695'Pyrrolotriazine compounds as kinase inhibitors'20077,163,917'Synthesis method of alanylglutamine'20077,151,176'Pyrrolotriazine compounds'20067,141,571'Pyrrolotriazine compounds as kinase inhibitors'20066,953,780'Endothelin antagonist'20056,916,809'Heterocyclic acridone inhibitors of IMPDH enzyme'2005Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2005–2020Patents assigned to BRISTOL MYERS SQUIBB CO (24)· patent assignee history
2005–2020Based in Pennington, NJ, US· patent location history
2005Based in Beijing, CN· patent location history
2007–2013Patents assigned to ZHAO YUFEN (5)· patent assignee history
2007Based in Fujian, CN· patent location history
2011–2013Patents assigned to GAVAI ASHVINIKUMAR V (4)· patent assignee history
2011–2013Patents assigned to BALOG JAMES AARON (2)· patent assignee history
2012–2013Patents assigned to CHEN LIBING (2)· patent assignee history
2021Based in Linkoping, SE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BRISTOL MYERS SQUIBB CO | 24 | 2005–2020 |
| ZHAO YUFENself | 5 | 2007–2013 |
| GAVAI ASHVINIKUMAR V | 4 | 2011–2013 |
| BALOG JAMES AARON | 2 | 2011–2013 |
| CHEN LIBING | 2 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pennington, New Jersey, US | 24 | 2005–2020 |
| Linkoping, SE | 1 | 2021 |
| Fujian, CN | 1 | 2007 |
| Beijing, CN | 1 | 2005 |